Clinical Study
Influence of the Type of Basal Insulin and Other Variables on Clinical Outcomes in Children with Newly Diagnosed Type 1 Diabetes
Table 1
Baseline characteristics.
| | Glargine | Detemir | Significance |
| Average age (years) | 10.9 ± 4.4 | 10.1 ± 3.6 | | Male gender | 58% | 59% | | Caucasian ethnicity | 76% | 77% | | Hypothyroidism | 5% | 7% | | Private insurance | 50% | 70% | | DKA at diagnosis | 24% | 16% | | Flexible dosing | 87% | 91% | | HbA1c at diagnosis | 11.8 ± 1.9 | 11.5 ± 2.4 | | BMI percentile | 45.2% ± 33.0% | 43.3% ± 34.7% | | Mean daily insulin dose by unit/kg | 0.70 ± 0.14 | 0.66 ± 0.16 | | Aspart as rapid insulin | 68% | 100% | | Completion of education visits | 87% | 91% | |
|
|